Home › Funds › ACUTA CAPITAL PARTNERS, LLC › WHWK

ACUTA CAPITAL PARTNERS, LLC position in WHWK

WHITEHAWK THERAPEUTICS INC · Health Care

ACUTA CAPITAL PARTNERS, LLC reported holding 4,685,912 shares of WHWK (WHITEHAWK THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$21.5M, representing 14.96% of its reported portfolio and ranking #2 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC has disclosed WHWK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)4.69M sh
Reported value held$21.46M
Portfolio Weight14.96%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ACUTA CAPITAL PARTNERS, LLC's WHWK position evolved

ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in WHWK in Q3 2023 at 1,849,402 shares (US$9.0M). The position peaked in Q2 2026 at 4,685,912 shares, worth US$21.5M. Across 12 filings, ACUTA CAPITAL PARTNERS, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 4,685,912 shares valued at US$21.5M — an increase of 1,275,510 shares quarter over quarter.. Notable position changes include a 84% increase in Q1 2025 (shares rose 5% over the following quarter), a 37% increase in Q2 2026 (shares fell 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.85M $8.95M New
Q4 2023 1.85M $3.74M Hold
Q1 2024 1.85M $4.33M Hold
Q2 2024 1.85M $2.70M Hold
Q3 2024 1.85M $3.81M Hold
Q4 2024 1.85M $5.83M Hold
Q1 2025 3.41M $6.07M Add
Q2 2025 3.41M $6.38M Hold
Q3 2025 3.41M $6.48M Hold
Q4 2025 3.41M $8.25M Hold
Q1 2026 3.41M $11.77M Hold
Q2 2026 4.69M $21.46M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WHWK and 13F data

WHWK (WHITEHAWK THERAPEUTICS INC) is a Health Care company. 48 other funds we track also report a position in WHWK — the largest reported positions include Yu Fan (US$22.3M), QVT Financial LP (US$21.1M), MONTANOVA CAPITAL, LLC (US$19.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WHWK

All WHWK fund holders →

FAQ

How long has ACUTA CAPITAL PARTNERS, LLC held WHWK?

ACUTA CAPITAL PARTNERS, LLC has disclosed WHWK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is ACUTA CAPITAL PARTNERS, LLC's current position in WHWK?

As of Q2 2026, ACUTA CAPITAL PARTNERS, LLC holds 4.69M shares of WHWK (WHITEHAWK THERAPEUTICS INC), valued at $21.46M, representing 14.96% of its reported portfolio and ranking #2.

Has ACUTA CAPITAL PARTNERS, LLC been buying or selling WHWK?

In the latest 13F filing (Q2 2026), ACUTA CAPITAL PARTNERS, LLC increased its position in WHWK. The position peaked in Q2 2026 at 4.69M shares.

Which other funds hold WHWK?

Other major institutional holders of WHWK include Yu Fan, QVT Financial LP, MONTANOVA CAPITAL, LLC, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.